Lilly & Co Eli's Net Worth

-$1.63 Billion

Who is Lilly & Co Eli?

Lilly & Co Eli does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Prevail Therapeutics Inc., Sigilon Therapeutics, Inc., Avidity Biosciences, Inc., Dermira, Inc., Elanco Animal Health Inc, Zymeworks Inc., LEAP THERAPEUTICS, INC., CoLucid Pharmaceuticals, Inc., Aeglea BioTherapeutics, Inc., Coherus BioSciences, Inc., Cerulean Pharma Inc., UNITED THERAPEUTICS Corp, ICAGEN INC, Zosano Pharma Corp, ISIS PHARMACEUTICALS INC, Receptos, Inc., and Akouos, Inc..

SEC CIK

Lilly & Co Eli's CIK is 0000059478

Past Insider Trading and Trends

2014 was Lilly & Co Eli's most active year for acquiring shares with 8 total transactions. Lilly & Co Eli's most active month to acquire stocks was the month of March. 2018 was Lilly & Co Eli's most active year for disposing of shares, totalling 17 transactions. Lilly & Co Eli's most active month to dispose stocks was the month of July. 2017 saw Lilly & Co Eli paying a total of $896,757,522.00 for 19,285,108 shares, this is the most they've acquired in one year. In 2011 Lilly & Co Eli cashed out on 1,050,281 shares for a total of $100,837,022.62, their largest year based on trade value.